ROST is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The business quality and analyst outlook are still solid, but the stock looks fully valued after a strong rerating, insider selling is elevated, and the technical setup is not signaling a clean entry. Since the user is impatient and wants a direct answer, I would not buy it today.
Current price is 213.05, essentially flat versus the previous close of 213.43. The short-term trend is weak-to-neutral: MACD histogram is -2.665 and below zero, which suggests downside momentum is still present, while RSI_6 at 33.153 shows the stock is near oversold but not yet a clear reversal signal. Moving averages are converging, which points to a consolidation phase rather than a confirmed uptrend. Key levels show near-term support at 209.003 and resistance at 222.38; the stock is trading below the pivot, so the chart does not currently favor aggressive new buying. The model trend data also suggests modest near-term weakness.

["Ross Stores continues to receive generally constructive analyst coverage, with several firms maintaining Buy/Overweight ratings and raising price targets.", "Barclays highlighted very strong Q1 comp sales growth of 17%, indicating healthy demand and execution.", "Truist sees long-term growth potential from store expansion, execution, and improving customer traction.", "Ross remains a strong off-price retailer with a proven value proposition that can benefit in a resilient consumer down-trade environment."]
["Wells Fargo downgraded the stock to Equal Weight from Overweight, citing valuation after the re-rating and saying the easy money has already been made.", "Insiders are selling, and the selling amount increased 955.19% over the last month.", "No recent news catalysts were available in the past week, so there is no fresh event-driven upside driver.", "The technical setup is not confirming momentum, and the stock is below pivot resistance.", "Options flow is heavily put-biased, signaling cautious near-term sentiment.", "Model trend data suggests the stock may drift lower over the next month."]
Latest quarter financial data was not provided due to an error, so a full quarter-by-quarter assessment is not available. However, the available analyst commentary indicates the latest reported quarter was strong, especially with Q1 comparable sales up 17%, which is well above expectations. That suggests the company is still showing healthy top-line growth in the latest season referenced by analysts.
Wall Street remains mixed but still constructive overall. Recent actions include Barclays raising its target to $260 and keeping Overweight, Citi raising to $261 with a Buy, Guggenheim raising to $290 with a Buy, JPMorgan raising to $251 with Overweight, and Truist initiating at Buy with $270. UBS is more cautious with a Neutral rating and $227 target, and Wells Fargo recently downgraded to Equal Weight with a $245 target, citing valuation. The pros view is that Ross has excellent execution, strong comps, and long-term expansion potential. The cons view is that the stock has already re-rated, upside may be more limited from here, and near-term risks include tougher comparisons, valuation, and inventory build concerns.